Literature DB >> 24479839

The influence of the initiation of an exercise programme on seroma formation and dehiscence following breast cancer surgery.

Eliana L Petito1, Marcella T Esteves, Simone Elias, Gil Facina, Afonso C P Nazário, Maria G R Gutiérrez.   

Abstract

AIMS AND
OBJECTIVES: To verify whether early (first post-operative day) or late initiation (after removal of the continuous suction drain) of a functional rehabilitation exercise programme influences the incidence of seroma formation and dehiscence for women after breast cancer surgery.
BACKGROUND: Benefits of early implementation of an exercise programme initiated with women in the first days following breast cancer surgery are widely known. However, the safe initiation of the exercises is still a controversial issue and some authors correlate early initiation of the exercises with an increase in seroma formation.
DESIGN: A prospective, randomised, controlled clinical trial.
METHODS: Seventy-seven women were randomly assigned to initiate the programme on post-operative day 1 (early group = 40) or after removal of the drain (late group = 37) and were monitored until the 45th post-operative day. Patients in the early group were instructed to perform the exercises daily at home, beginning on post-operative day 1, while those of the late group began the exercises after the drain was removed. The assessment for seroma formation and dehiscence was performed on post-operative days 7 and 45.
RESULTS: There was no statistically significant difference regard to seroma formation between early group and late group. Also there was no association between the presence of dehiscence and early exercises.
CONCLUSION: The early initiation of the exercises for women, following breast cancer surgery, constitutes a safe practice for the rehabilitation. However, these findings need to be further explored and confirmed in a larger sample. RELEVANCE TO CLINICAL PRACTICE: Studies showing evidence that early functional rehabilitation process is a safe practice for women having surgery for breast cancer, as well as the present research, are of interest to health professionals who care for these patients and contribute to the wider global clinical community.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  breast neoplasms; dehiscence; exercises; seroma

Mesh:

Year:  2014        PMID: 24479839     DOI: 10.1111/jocn.12544

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  Teaching of Independent Exercises for Prehabilitation in Breast Cancer.

Authors:  Jennifer Baima; Sara-Grace Reynolds; Kathryn Edmiston; Anne Larkin; B Marie Ward; Ashling O'Connor
Journal:  J Cancer Educ       Date:  2017-06       Impact factor: 2.037

2.  A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment.

Authors:  Helena Harder; Patrick Holroyd; Lynn Burkinshaw; Phil Watten; Charles Zammit; Peter R Harris; Anna Good; Val Jenkins
Journal:  J Cancer Surviv       Date:  2017-07-24       Impact factor: 4.442

3.  Serial image changes in ultrasonography after the excision of benign breast lesions by mammotome® biopsy system.

Authors:  Yu Ding; Lili Cao; Ju Chen; Elena Karamfilova Zaharieva; Yanbin Xu; Liang Li
Journal:  Saudi J Biol Sci       Date:  2018-08-17       Impact factor: 4.219

4.  Quilting following mastectomy reduces seroma, associated complications and health care consumption without impairing patient comfort.

Authors:  Lotte J van Zeelst; Britt Ten Wolde; Ramon R J P van Eekeren; José H Volders; Johannes H W de Wilt; Luc J A Strobbe
Journal:  J Surg Oncol       Date:  2021-11-16       Impact factor: 2.885

Review 5.  Conservative interventions and clinical outcome measures used in the perioperative rehabilitation of breast cancer patients undergoing mastectomy: a scoping review.

Authors:  Janny Mathieu; Catherine Daneau; Nadège Lemeunier; Annabelle Doyon; Andrée-Anne Marchand; Martin Descarreaux
Journal:  BMC Womens Health       Date:  2022-08-16       Impact factor: 2.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.